Skip to contents

Carlo Giovanni Traverso, MD, PhD
Associate Physician, Brigham and Women's Hospital
Assistant Professor, Harvard Medical School

Brigham and Women's Hospital
Department of Medicine
75 Francis Street
Boston, MA 02115

Edit Profile

Research Narrative:
C. Giovanni Traverso, MB, BChir, PhD is an Assistant Professor of Medicine (part-time) at Harvard Medical School, and a Gastroenterologist in the Division of Gastroenterology at Brigham and Women’s Hospital. And an Assistant Professor in the Department of Mechanical Engineering at the Massachusetts Institute of Technology.
Dr. Traverso received his medical degrees from the University of Cambridge and completed his Internal Medicine residency training at the Brigham and Women’s Hospital (BWH).  He subsequently completed his fellowship in Gastroenterology at Massachusetts General Hospital (MGH) and joined the faculty of the MGH in 2014. He transitioned back to BWH in 2016.
Dr. Traverso completed his PhD thesis on novel technologies for the non-invasive detection of colorectal cancer from fecal DNA in the laboratory of Professor Bert Vogelstein at Johns Hopkins University.  For his post-doctoral research he transitioned to the fields of chemical and biomedical engineering in the laboratory of Professor Robert Langer at the Massachusetts Institute of Technology (MIT) where he developed a series of novel technologies for drug delivery as well as physiological sensing via the gastrointestinal tract.
His current research program is focused on developing the next generation of drug delivery and sensing systems to enable efficient diagnosis and delivery of therapeutics.

Dr. Traverso’s research program is focused on developing novel technologies for drug delivery  and sensing.  His work aims to enable a broader spectrum of therapeutics to be delivered through the GI tract, to extend the duration of drug release after a single administration event, as well as to enhance precision in localization of drug delivery, to maximize drug delivery to areas of disease while minimizing side effects from drugs in non-diseased tissues.  Additionally, Dr. Traverso and his team are developing a broad of systems to sense signals from the body to support the continuous monitoring of disease.    The overall goal of Dr. Traverso’s research is to develop innovative technologies to advance the delivery of therapeutics as well as sensing of pathologic and physiologic signals in order to help patients receive treatment through the most facile, effective and targeted means possible.
Dr. Traverso also has a long-standing research interest in the molecular underpinnings of cancer, and how understanding these can be applied for early detection and treatment.